Improving access to HIV prevention for Black women in the South
PrEP 4 Her: Developing a Novel Strategy to Implement PrEP into Women's Healthcare
['FUNDING_OTHER'] · UNIVERSITY OF ALABAMA AT BIRMINGHAM · NIH-10682433
This study is working to help Black women in the Southern U.S. learn more about and access HIV prevention medication called PrEP, by making it easier to get and understand at places they already visit for care.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ALABAMA AT BIRMINGHAM (nih funded) |
| Locations | 1 site (BIRMINGHAM, UNITED STATES) |
| Trial ID | NIH-10682433 on ClinicalTrials.gov |
What this research studies
This research aims to enhance the uptake of HIV pre-exposure prophylaxis (PrEP) among Black cis-gender women in the Southern United States, a group that has been disproportionately affected by HIV. The project will implement behavioral interventions to create demand for PrEP, such as community distribution and scheduling appointments during local events. By focusing on Title X family planning clinics, where these women already receive care, the research seeks to address barriers like low awareness and stigma surrounding PrEP. The goal is to improve access and utilization of this effective prevention tool in communities that need it most.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black cis-gender women living in the Southern United States who are at risk for HIV.
Not a fit: Patients who are not Black cis-gender women or those who are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce HIV transmission rates among Black cis-gender women by increasing their access to PrEP.
How similar studies have performed: Previous research has shown that targeted behavioral interventions can improve health outcomes in similar populations, indicating potential for success in this approach.
Where this research is happening
BIRMINGHAM, UNITED STATES
- UNIVERSITY OF ALABAMA AT BIRMINGHAM — BIRMINGHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ELOPRE, LATESHA ELLEN — UNIVERSITY OF ALABAMA AT BIRMINGHAM
- Study coordinator: ELOPRE, LATESHA ELLEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.